Helus Pharma Inc. (HELP) Earnings History
Net Loss10 years of earnings data (2017–2026) · Currently unprofitable on a TTM basis
Loading earnings history...
Helus Pharma Inc. (HELP) Earnings Overview
As of November 8, 2026, Helus Pharma Inc. (HELP) reported trailing twelve-month net income of -$183M, reflecting +24.3% year-over-year growth. The company earned $-3.50 per diluted share over the past four quarters, with a net profit margin of 329.1%.
Looking at the long-term picture, HELP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$101,000 in fiscal 2019.
Helus Pharma Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$266M net income), DFTX (-$354M net income), SILO (-$4M net income, -5863.5% margin), HELP has comparable earnings metrics. Compare HELP vs CMPS →
HELP Earnings vs Peers
Earnings metrics vs comparable public companies
HELP Historical Earnings Data (2017–2026)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | -$147M | -30.0% | -$142M | $-4.23 | - | - |
| 2025 | -$113M | -44.9% | -$143M | $-5.59 | -23956.0% | -30310.4% |
| 2024 | -$78M | -64.4% | -$79M | $-9.41 | - | - |
| 2023 | -$47M | +29.8% | -$52M | $-9.74 | -18919.2% | -20523.9% |
| 2022 | -$68M | -109.9% | -$64M | $-15.36 | -40314.1% | -38053.2% |
| 2021 | -$32M | -1557.4% | -$31M | $-12.24 | -3729.2% | -3592.0% |
| 2020 | -$2M | -1824.8% | -$2M | $-1.82 | - | - |
| 2019 | $-101,000 | +54.3% | $-80,520 | $-0.28 | - | - |
| 2018 | $-220,806 | -73.9% | $-189,946 | $-0.69 | - | - |
| 2017 | $-127,000 | - | $-127,000 | $-0.35 | - | - |
Download Data
Export HELP earnings history in CSV or JSON format
Free sign-in required to download data
HELP Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HELP — Frequently Asked Questions
Quick answers to the most common questions about buying HELP stock.
What is HELP earnings per share (EPS)?
HELP trailing twelve-month (TTM) diluted EPS is $-3.50, reflecting +24.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2026 is available in the table on this page.
What is Helus Pharma Inc.'s net income?
Helus Pharma Inc. (HELP) trailing twelve-month net income is $-183M as of 2026. Earnings grew +24.3% year-over-year.
Is HELP profitable?
HELP is not currently profitable on a TTM basis, reporting a net loss of $-183M. Net margin is +329.1%. Investors should monitor for a return to profitability.
What is HELP's earnings growth rate?
HELP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2026.
What are HELP's profit margins?
Helus Pharma Inc. net profit margin is +329.1%, operating margin is +317.1%, and gross margin is +100.3%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is -62.7%.
Is HELP growing earnings?
Yes, HELP earnings are accelerating — EPS growth of +24.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-183M. Earnings momentum is strengthening.
What was HELP's best earnings year?
Helus Pharma Inc.'s highest annual net income on record is $-101000.00, achieved in fiscal year 2019. Earnings history on this page spans 2017 to 2026 and includes all annual and quarterly figures.
What were HELP's earnings last quarter?
HELP's most recent reported quarter was Q1 2027. Net income was $-47M with diluted EPS of $-0.89. For a full breakdown of all quarters, see the quarterly earnings table on this page.